Deep Tech · VC Firm · Active
Oxford Science Enterprises
Oxford Science Enterprises is the founder-investor partner of the University of Oxford, with exclusive first-look rights on physics and engineering spin-outs from the Clarendon and Department of…
Investment thesis
Oxford Science Enterprises is the founder-investor partner of the University of Oxford, with exclusive first-look rights on physics and engineering spin-outs from the Clarendon and Department of Materials labs. Its quantum thesis spans three hardware modalities incubated inside the university — trapped-ion (Oxford Ionics), superconducting (Oxford Quantum Circuits) and photonic (ORCA Computing) — giving the firm a rare multi-modality seat at the UK quantum table. OSE typically writes the first institutional check at formation, then follows into Series A and B alongside specialist deep-tech co-investors. The Oxford Ionics acquisition by IonQ in 2025 validated the trapped-ion thesis with a $1.1bn exit. As an evergreen vehicle it can hold hardware companies through the 10-15 year path to commercialisation without fund-life pressure. Portfolio construction leans toward capital-intensive spin-outs where Oxford IP and talent are the moat.
Anti-thesis
The patterns that trigger a fast no with this fund.
- Pure-mandate filter: invests only in spinouts from Oxford's Medical Sciences and MPLS divisions, non-Oxford quantum companies are not investable, period
- Stage focus is pre-seed and seed with follow-on through exit: they will not parachute into a non-Oxford late-stage quantum round
- Will not be a passive co-investor outside Oxford: their value-add is Oxford-ecosystem dependent (lab access, EIR, follow-on conviction), founders shopping for a generic lead get redirected
- Less appetite for quantum plays without a clearly defensible Oxford IP licence: pure-team spinouts with no university IP backing have a higher bar
Notable quantum portfolio
Full portfolio →Reach out to Oxford Science Enterprises
A cold email and a 1-page brief, ready in two clicks.